Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07361653) titled 'The REVIVE Pivotal Study' on Jan. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Ryme Medical, Inc.
Condition:
COPD (Chronic Obstructive Pulmonary Disease)
COPD Exacerbations
COPD Patients
COPD Acute Exacerbation
COPD
Lung Disease Airways
Lung Disease, Chronic Obstructive
Intervention:
Device: Ryme TLD
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 2026
Target Sample Size: 300
To know more, visit https:/...